For example, mutations in BCL7A are, together with those in BCL6, highly enriched in the endemic subtype of BL, which is associated with Epstein-Barr virus (EBV) infection, whereas mutations in SMARCA4 are enriched in the sporadic subtype, which is usually EBV-negative [122, 138]. Here, SMARCA4 is linked to Burkitt lymphoma.